Literature DB >> 18699777

Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus.

Najet Srairi-Abid1, Delavar Shahbazzadeh, Imen Chatti, Saoussen Mlayah-Bellalouna, Hafedh Mejdoub, Lamia Borchani, Rym Benkhalifa, Abolfazl Akbari, Mohamed El Ayeb.   

Abstract

Hemitoxin (HTX) is a new K+ channel blocker isolated from the venom of the Iranian scorpion Hemiscorpius lepturus. It represents only 0.1% of the venom proteins, and displaces [125 I]alpha-dendrotoxin from its site on rat brain synaptosomes with an IC50 value of 16 nm. The amino acid sequence of HTX shows that it is a 35-mer basic peptide with eight cysteine residues, sharing 29-69% sequence identity with other K+ channel toxins, especially with those of the alphaKTX6 family. A homology-based molecular model generated for HTX shows the characteristic alpha/beta-scaffold of scorpion toxins. The pairing of its disulfide bridges, deduced from MS of trypsin-digested peptide, is similar to that of classical four disulfide bridged scorpion toxins (Cys1-Cys5, Cys2-Cys6, Cys3-Cys7 and Cys4-Cys8). Although it shows the highest sequence similarity with maurotoxin, HTX displays different affinities for Kv1 channel subtypes. It blocks rat Kv1.1, Kv1.2 and Kv1.3 channels expressed in Xenopus oocytes with IC50 values of 13, 16 and 2 nM, respectively. As previous studies have shown the critical role played by the beta-sheet in Kv1.3 blockers, we suggest that Arg231 is also important for Kv1.3 versus Kv1.2 HTX positive discrimination. This article gives information on the structure-function relationships of Kv1.2 and Kv1.3 inhibitors targeting developing peptidic inhibitors for the rational design of new toxins targeting given K+ channels with high selectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18699777     DOI: 10.1111/j.1742-4658.2008.06607.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  12 in total

1.  A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.

Authors:  Najmeh Yardehnavi; Mahdi Behdani; Kamran Pooshang Bagheri; Amir Mahmoodzadeh; Hossein Khanahmad; Delavar Shahbazzadeh; Mahdi Habibi-Anbouhi; Gholamreza Hassanzadeh Ghassabeh; Serge Muyldermans
Journal:  FASEB J       Date:  2014-06-02       Impact factor: 5.191

2.  The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.

Authors:  Xiao-Fang Yang; Yong Yang; Yi-Tian Lian; Zhao-Hui Wang; Xiao-Wei Li; Long-Xian Cheng; Jin-Ping Liu; Yan-Fu Wang; Xiang Gao; Yu-Hua Liao; Min Wang; Qiu-Tang Zeng; Kun Liu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Discovery of Leptulipin, a New Anticancer Protein from theIranian Scorpion, Hemiscorpius lepturus.

Authors:  Ali Rezaei; Saeme Asgari; Samira Komijani; Seyedeh Narjes Sadat; Jean-Marc Sabatier; Davood Nasrabadi; Kamran Pooshang Bagheri; Delavar Shahbazzadeh; Mohammad Reza Akbari Eidgahi; Michel De Waard; Hasan Mirzahoseini
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

4.  First report of death due to Hemiscorpius acanthocercus envenomation in Iran: Case report.

Authors:  Mehran Shahi; Javad Rafinejad; Leyla Az-Khosravi; Seyed Hamid Moosavy
Journal:  Electron Physician       Date:  2015-09-16

Review 5.  Scorpion sting nephropathy.

Authors:  Stalin Viswanathan; Chaitanya Prabhu
Journal:  NDT Plus       Date:  2011-12

6.  Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats.

Authors:  Khalil Pourkhalili; Euikyung Kim; Navid Reza Mashayekhy; Mostafa Kamyab; Seyed Mehdi Hoseiny; Reihane Evazy; Abbas Zare Mirakabadi; Ramin Seyedian
Journal:  J Arthropod Borne Dis       Date:  2015-03-11       Impact factor: 1.198

Review 7.  Epidemiological review of scorpion envenomation in iran.

Authors:  Amir Jalali; Fakher Rahim
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

8.  Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1).

Authors:  Rezvan Zabihollahi; Kamran Pooshang Bagheri; Zohreh Keshavarz; Fatemeh Motevalli; Golnaz Bahramali; Seyed Davar Siadat; Seyed Bahman Momen; Delavar Shahbazzadeh; Mohammad Reza Aghasadeghi
Journal:  Iran Biomed J       Date:  2016-09-04

Review 9.  Scorpionism by Hemiscorpius spp. in Iran: a review.

Authors:  Rouhullah Dehghani; Fatemeh Kamiabi; Malihe Mohammadi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-03-02

10.  Characteristics and Lethality of a Novel Recombinant  Dermonecrotic Venom Phospholipase D from  Hemiscorpius lepturus.

Authors:  Elham Torabi; Mahdi Behdani; Mohammad Hosseininejad Chafi; Reza Moazzami; Jean-Marc Sabatier; Vahid Khalaj; Delavar Shahbazzadeh; Kamran Pooshang Bagheri
Journal:  Toxins (Basel)       Date:  2017-03-13       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.